Therapies developed on a foundation of experience
We have a deep understanding of and experience in nervous system research, product development and commercialization. This expertise enables us to focus on therapies that have a potential to improve the lives of people with MS, SCI and other neurological conditions. In this section you can learn more about AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg as well as medications that we are studying to treat a range of neurological disorders.Product Pipeline
Acorda is dedicated to the development and commercialization of novel therapies to improve, repair and restore neurological function in people with a range of nervous system disorders, including multiple sclerosis (MS), spinal cord injury (SCI), stroke and traumatic brain injury (TBI).LEARN MORE
